RPBG patients benefiting from new at home treatment
14 May 2021
Immunoglobulin (Ig) therapy is used to treat patients who are deficient in immunoglobulins (antibodies), which are a vital part of the body’s defence against foreign invaders like bacteria, or viruses.
Patients who have specific haematology, neurology or immunology-based conditions are often required to participate in time consuming treatments at RPH every three to four weeks.
The Ig treatment can typically take anywhere between three and eight hours to administer, resulting in the patient attending the hospital for extended periods of time.
However, for the past nine months, the Standard 7 Blood Management Committee have been working on the development of a self-administered Subcutaneous Immunoglobulin (SCIg) treatment, which could see patients administer the treatment from the comfort of their own home, offering greater freedom and flexibility around when and where they receive their treatment.
Paula (pictured), who has a neurology condition called Chronic Inflammatory Demyelinat...